Assenagon Asset Management S.A. Reata Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$30.85 - $93.17 $10.7 Million - $32.4 Million	347,961 New	347,961 $31.6 Million
Q1 2022 Apr 25, 2022	SELL	$24.12 - $39.6 $4.16 Million - $6.82 Million	-172,323 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$25.61 - $110.96 $4.41 Million - $19.1 Million	172,323 New	172,323 $4.54 Million
Q2 2020 Jul 21, 2020	SELL	$126.3 - $176.56 $3.97 Million - $5.56 Million	-31,463 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$124.16 - $247.74 $725,342 - $1.45 Million	-5,842 Reduced 15.66%	31,463 $4.54 Million
Q4 2019 Jan 17, 2020	BUY	$74.57 - $217.92 $2.78 Million - $8.13 Million	37,305 New	37,305 $7.63 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.